A small piece of human growth hormone (specifically the fat-burning part, amino acids 176-191). It tells your body to break down fat and stop storing new fat, but without the muscle-growing or blood sugar effects of full growth hormone.
What to Expect
Week 1–2
Minimal noticeable effects initially. Fat metabolism changes beginning at cellular level. May notice slight increase in energy.
Week 3–6
Mild fat loss, particularly in stubborn areas. Improved exercise-induced fat oxidation. No effect on blood glucose or IGF-1 (a key safety advantage).
Week 8+
Moderate fat loss. Improved body composition. Potential cartilage repair benefits. Weight loss is more modest than incretin agonists.
Common Side Effects
Dosing
300 mcg subq daily on an empty stomach, typically in the morning. Cycle for 12 weeks.
Practical Guide
Reconstitution
Mix 5mg vial with 2mL BAC water. Typical dose is 250-500mcg.
Storage
Refrigerate after reconstitution. Use within 30 days.
Injection Sites
Subcutaneous injection near target fat deposits. Insulin syringe. Rotate sites.
Timing
Morning dosing on empty stomach or before fasted cardio for optimal fat oxidation synergy.
Food
Inject on empty stomach, ideally fasted. No food for 30 minutes after injection.
Benefit Profile
Medical Considerations
Contraindications
- ✕Pregnancy/nursing
- ✕Active cancer
Drug Interactions
Recommended Monitoring
- →Fasting glucose (should not be affected unlike full GH)
- →Body composition tracking for efficacy
This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol.
Published Research
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Human sports drug testing by mass spectrometry.
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
Obesity drugs in clinical development.
AOD-9604 Metabolic.
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Detection and in vitro metabolism of AOD9604.
Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.
Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.